Boston College Center for Corporate Citizenship Report Illustrates the Role of Corporate Citizenship in Business Success
CHESTNUT HILL, Mass., Jaunary 26, 2017 /3BL Media/—Boston College Center for Corporate Citizenship is pleased to release the 2017 State of Corporate Citizenship, a unique research report that examines how executives view corporate citizenship in both business and global contexts, and identifies the topics and issues they find most important.
Funds to support results-driven research and community projects engaged in HIV cure activities
FOSTER CITY, Calif., January 11, 2017 /3BL Media/ -- Gilead Sciences, Inc.(Nasdaq:GILD) today announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects.
In 2016, Sanofi has risen 2 positions in the Access To Medicine (ATM) Index, from 8th to 6th rank. The ATM Index analyses the top 20 research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries.
Sanofi’s performance is well recognized this year in the two main areas, which represent 45% of the overall score and are major enablers of access: